טוען...
Outcomes Following Neoadjuvant or Adjuvant Chemotherapy for cT2-4N0-1 Non-Small Cell Lung Cancer: A Propensity-Matched Analysis
OBJECTIVE: Comparative survival between neoadjuvant chemotherapy (NC) and adjuvant chemotherapy (AC) for patients with cT2-4N0-1M0 non-small cell lung cancer (NSCLC) has not been extensively studied. METHODS: Patients with cT2-4N0-1M0 NSCLC who received platinum-based chemotherapy were retrospective...
שמור ב:
| הוצא לאור ב: | J Thorac Cardiovasc Surg |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6344258/ https://ncbi.nlm.nih.gov/pubmed/30415902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.09.098 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|